23. CBD products that fulfill the definition of a CBPM will be Class B managed medications and subject matter to Regulation 16A as well as the appropriate restrictions for Agenda 2 medications [footnote five]. CBD products that fulfill the definition of the cannabis-dependent drugs which has been individually scheduled might be Class B drugs in the